Cancer Research UK logo.
SearchDonate
  • Search

About Cancer

Essential Thrombocythaemia (ET)

Essential thrombocythaemia (ET) is a rare blood cancer that causes a high number of blood cells called platelets to form. These cells are involved in blood clotting. It is one of a group of conditions called myeloproliferative neoplasms.

We have information on the diagnosis and treatment of essential thrombocythaemia. And information on organisations that provide support to help you cope.

Get more information on other myeloproliferative neoplasms

What is essential thrombocythaemia (essential thrombocytosis)?

Essential thrombocythaemia is a rare blood cancer It causes a high number of blood cells called platelets to form.

Tests and treatment for essential thrombocythaemia (ET)

The first test to diagnose essential thrombocythaemia is usually a blood test. This is to check the number of platelets in your blood. In ET there is an abnormally high level of platelets.

Research and coping with essential thrombocythaemia (ET)

Researchers around the world are looking at better ways to treat essential thrombocythaemia and manage treatment side effects.

Last reviewed: 21 Nov 2023

Next review due: 21 Nov 2026

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and Support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.